Table of Content

Open Access iconOpen Access

ARTICLE

Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection

José L. Aparicio1, Macarena Ottobre1, Maite Duhalde Vega1, Jean-Paul Coutelier2, Jacques Van Snick3, Lilia A. Retegui1

1 Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia y Bioquímica, Buenos Aires, Argentina
2 Unit of Experimental Medicine, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
3 Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium

* Corresponding Authors: Lilia A. Retegui, email, liliaretegui@fibertel.com.ar

European Cytokine Network 2017, 28(3), 111-119. https://doi.org/10.1684/ecn.2017.0399

Abstract

Mice infected with mouse hepatitis virus A59 (MHV-A59) develop hepatitis and autoantibodies (autoAb) to liver and kidney fumarylacetoacetate hydrolase (FAH), a fact closely related to the release of alarmins such as uric acid and/or high-mobility group box protein 1 (HMGB1). We studied the effect of neutralizing monoclonal antibodies (MAb) against IL-17A in our model of mouseMHV-A59-infection.MAb anti-IL-17F and anti-IFNγ were used to complement the study. Results showed that transaminase levels markedly decreased in MHV-A59- infected mice treated with MAb anti-IL-17A whereas plasmatic Ig concentration sharply increased. Conversely, MAb anti-IL-17F enhanced transaminase liberation and did not affect Ig levels. Serum IFNγ was detected in mice infected with MHV-A59 and its concentration increased after MAb anti-IL-17A administration. Besides, MAb anti-IFNγ greatly augmented transaminase plasmatic levels. IL-17A neutralization did not affect MHV-A59-induction of HMGB1 liberation and slightly augmented plasmatic uric acid concentration. However, mice treated with the MAb failed to produce autoAb to FAH. The above results suggest a reciprocal regulation of Th1 and Th17 cells acting on the different MHV-A59 effects. In addition, it is proposed that IL-17A is involved in alarmins adjuvant effects leading to autoAb expression.

Keywords

mouse hepatitis virus, interleukin 17A, interleukin 17F, autoantibodies, IFNγ

Cite This Article

APA Style
Aparicio, J.L., Ottobre, M., Vega, M.D., Coutelier, J., Snick, J.V. et al. (2017). Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection. European Cytokine Network, 28(3), 111–119. https://doi.org/10.1684/ecn.2017.0399
Vancouver Style
Aparicio JL, Ottobre M, Vega MD, Coutelier J, Snick JV, Retegui LA. Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection. Eur Cytokine Network. 2017;28(3):111–119. https://doi.org/10.1684/ecn.2017.0399
IEEE Style
J.L. Aparicio, M. Ottobre, M.D. Vega, J. Coutelier, J.V. Snick, and L.A. Retegui, “Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection,” Eur. Cytokine Network, vol. 28, no. 3, pp. 111–119, 2017. https://doi.org/10.1684/ecn.2017.0399



cc Copyright © 2017 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 33

    View

  • 14

    Download

  • 0

    Like

Share Link